MONTREAL, November 1st, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive distribution agreement with Iogen Oy for its I-DROP® and I-LID ’N LASH® product lines, as well as the I-RELIEFTM HOT & COLD THERAPY EYE MASK with THERMABEADSTM […]
I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the U.S Market. MONTREAL, October 17, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive distribution agreement with Quidel Corporation, a leading provider of […]
Montreal, February 20, 2018 (GLOBE NEWSWIRE) – On February 14th TearLab issued a press release indicating it will appeal after its defeat in a patent infringement action against I-MED Pharma Inc. in Canada. In the press release, it was stated “The I-PEN® did indeed infringe the TearLab patent; however, specific claims in the patent were […]
Montreal, February 13, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., announced today that TearLab’s efforts to keep the I-PEN® Osmolarity System off the market proved unsuccessful. I-MED Pharma wins patent case against TearLab, with costs awarded to I-MED. In February 2016, TearLab brought a suit in the Federal Court of Canada alleging that the I-PEN® […]
(I-MED Pharma) I-MED PHARMA Inc., Your Leader in Ocular Surface Disorder Management, is proud to announce the launch of our new and improved website www.imedpharma.com. This site contains a comprehensive list of all our OSD, diagnostic and surgical product offerings detailing their uses and unique benefits. From this site, you can be directed to our […]
